NL-OMON30594已完成不适用
A clinical RSA study using the Symax stem - RSA Symax hip
Stryker Howmedica0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •age between 18 and 70 years
- •Patients requiring uncemented primary THA
- •Patients with a diagnosis of osteoarthritis, rheumatoid arthritis, avascular necrosis or post-traumatic arthritis
排除标准
- •patients who require a revision of previous implanted THA
- •Patients with BMI>35
- •Patients who have had a prior procedure of femoral osteotomy
- •patients with active or suspected infection
- •patients with malignancy
研究者
相似试验
招募中
不适用
SiREX-Stent for the Treatment of SymptOmatic Lateral VEnous Sinus StenosisTreatment of Symptomatic Lateral Sinus StenosisNCT06726928Acandis GmbH78
已完成
不适用
RSA Study of Sirius Stem and Exceed CupOsteoarthritisNCT02307331Region Skane48
招募中
不适用
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip ArthroplastyDegenerative Hip Joint DiseasePost-traumatic OsteoarthritisHip ArthritisFemoral Neck FracturesFailure of Prosthetic Joint ImplantAvascular Necrosis of the Femoral HeadNCT05227924Dedienne Sante S.A.S.747
Unknown
不适用
Evaluation of the Safety and Performance of ESTYME® MATRIX Round and Anatomical Breast Implants - EMMIE StudyBreast AugmentationBreast ReconstructionNCT03386682Symatese Aesthetics50
进行中（未招募）
1 期
A PHASE I/II TRIAL OF THE USE OF SIROLIMUS (RAPAMUNE) AND LOW DOSE ARA-C IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) - Ara-C and Sirolimus in AMAcute myeloid leukaemia (AML) and high risk myelodysplasia (MDS)EUCTR2005-002823-15-GBottingham University Hospitals NHS Trust